Analysis and Perspectives

Dec 06, 2021

TIGIT Inhibitor has been identified as a promising emerging immune checkpoint target due to its widespread expression on lymphocytes

Nov 29, 2021

The more recent and technologically advanced Migraine Neuromodulation Devices are proven to reduce pain and other migraine-related symptoms..

Nov 22, 2021

With the advent of several pipeline therapies, the Follicular Lymphoma Therapeutics Market is growing immensely. Globally, key companies li..

Nov 19, 2021

HIV Therapeutics Market is expected to evolve owing to the launch of novel therapies and the active participation of pharma companies...

Nov 05, 2021

IgA Nephropathy Treatment Market is evolving with the active participation of the key companies developing therapies and the rising incidence

Nov 03, 2021

Key factors such as advancement in technology, rising awareness, and keen interest by leading companies in the

Nov 01, 2021

In the first half of 2021, leading pharma companies have launched more than 12+ therapies, which includes Evkeeza, Lybalvi, Abecma, Lupykynis,

Oct 29, 2021

HIV-1 Therapeutics Market is expected to grow with the entry of novel therapies and the R&D activities by key companies including GSK, Merck,

Oct 27, 2021

The United States (US) tops the global pharmaceutical industry and accounts for 46% of total global revenue followed by China, Japan, Germany

Oct 25, 2021

von Willebrand Disease (vWD) treatment market in the US is categorized as Replacement therapy, Adjunct therapy, and Non-replacement therapy..